N21K (p.Asn21Lys) variant of BCL6 (B-cell lymphoma 6 protein)
N21K (p.Asn21Lys) in BCL6 (B-cell lymphoma 6 protein) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.37 / 1. The record also includes population frequency data.
N21K (p.Asn21Lys) variant details
- p.Asn21Lys
- NCI-TCGA Cosmic COSV5165
- cosmic curated COSV51656
- Variant assessed as somatic; moderate impact.
- Missense
- Variant Prioritization Score for Impact Estimate 0.365
- REVEL 0.40
- CADD 24.00
- PolyPhen-2 1.00
- SIFT 0.00
- UniProt: Variant assessed as somatic; moderate impact.
- Most common in the Non-Finnish European population (allele frequency 9e-07)